Hai-Gwo Hwu

Hai-Gwo Hwu

Auto-generated profile, based on publicly available information

Hai-Gwo Hwu

Department of Psychiatry, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1999 in Psychological Medicine
Verified
Journal Article
Closed access
PDF file
MWM. M. Weissman
M. M. Weissman
RBR. C. Bland
R. C. Bland
GCG. J. Canino
G. J. Canino
SGS. Greenwald
S. Greenwald
HHH.-G. Hwu
H.-G. Hwu
EYE.-K. Yeh
E.-K. Yeh
Background. There are few cross-national comparisons of the rates of suicide ideation and attempts across diverse countries. Nine independently conducted epidemiological surveys using similar diagnostic assessment and criteria provided an opportunity to obtain that data.Methods. Suicide ideation and attempts were assessed on the Diagnostic Interview Schedule in over 40000 subjects drawn from the United States, Canada, Puerto Rico, France, West Germany, Lebanon, Taiwan, Korea and New Zealand.Results. The lifetime prevalence rates/100 for suicide ideation ranged from 2·09 (Beirut) to 18·51 (Christchurch, New Zealand). Lifetime prevalence rates/100 for suicide attempts ranged from 0·72 (Beirut) to 5·93 (Puerto Rico). Females as compared to males had only marginally higher rates of suicidal ideation in most countries, reaching a two-fold increase in Taiwan. Females as compared to males had more consistently higher rates for suicide attempts, reaching a two- to three-fold increase in most countries. Suicide ideation and attempts in most countries were associated with being currently divorced/separated as compared to currently married.Conclusions. While the rates of suicide ideation varied widely by country, the rates of suicide attempts were more consistent across most countries. The variations were only partly explained by variation in rates of psychiatric disorders, divorce or separation among countries and are probably due to cultural features that we do not, as yet, understand.

1 April 1997 in Archives of General Psychiatry
Verified
Journal Article
Closed access
PDF file
MWMyrna M. Weissman
Myrna M. Weissman
RBRoger C. Bland
Roger C. Bland
GCGlorisa J. Canino
Glorisa J. Canino
CFCarlo Faravelli
Carlo Faravelli
SGSteven Greenwald
Steven Greenwald
EYEng-Kung Yeh
Eng-Kung Yeh
Background: Epidemiological data on panic disorder from community studies from 10 countries around the world are presented to determine the consistency of findings across diverse cultures. Method: Data from independently conducted community surveys from 10 countries (the United States, Canada, Puerto Rico, France, West Germany, Italy, Lebanon, Taiwan, Korea, and New Zealand), using the Diagnostic Interview Schedule andDSM-IIIcriteria and including over 40 000 subjects, were analyzed with appropriate standardization for age and sex differences among subjects from different countries. Results: The lifetime prevalence rates for panic disorder ranged from 1.4 per 100 in Edmonton, Alberta, to 2.9 per 100 in Florence, Italy, with the exception of that in Taiwan, 0.4 per 100, where rates for most psychiatric disorders are low. Mean age at first onset was usually in early to middle adulthood. The rates were higher in female than male subjects in all countries. Panic disorder was associated with an increased risk of agoraphobia and major depression in all countries. Conclusions: Panic disorder is relatively consistent, with a few exceptions, in rates and patterns across different countries. It is unclear why the rates of panic and other psychiatric disorders are lower in Taiwan.

1 November 1995 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
HMH.W. Moises
H.W. Moises
LYL. Yang
L. Yang
HKH. Kristbjarnarson
H. Kristbjarnarson
CWC. Wiese
C. Wiese
WBW. Byerley
W. Byerley
THT. Helgason
T. Helgason

30 December 2008 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
MNM Y M Ng
M Y M Ng
DLD F Levinson
D F Levinson
SFStephen V. V Faraone
Stephen V. V Faraone
BSB K Suarez
B K Suarez
LDL E DeLisi
L E DeLisi
CLCathryn Lewis
Cathryn Lewis
A genome scan meta-a nalysis (GSMA) was carried out on 32 independent genome-wide linkage scan analyses that included 3255 pedigrees with 7413 genotyped cases affected with schizophrenia (SCZ) or related disorders. The primary GSMA divided the autosomes into 120 bins, rank-ordered the bins within each study according to the most positive linkage result in each bin, summed these ranks (weighted for study size) for each bin across studies and determined the empirical probability of a given summed rank (PSR) by simulation. Suggestive evidence for linkage was observed in two single bins, on chromosomes 5q (142–168 Mb) and 2q (103–134 Mb). Genome-wide evidence for linkage was detected on chromosome 2q (119–152 Mb) when bin boundaries were shifted to the middle of the previous bins. The primary analysis met empirical criteria for ‘aggregate’ genome-wide significance, indicating that some or all of 10 bins are likely to contain loci linked to SCZ, including regions of chromosomes 1, 2q, 3q, 4q, 5q, 8p and 10q. In a secondary analysis of 22 studies of European-ancestry samples, suggestive evidence for linkage was observed on chromosome 8p (16–33 Mb). Although the newer genome-wide association methodology has greater power to detect weak associations to single common DNA sequence variants, linkage analysis can detect diverse genetic effects that segregate in families, including multiple rare variants within one locus or several weakly associated loci in the same region. Therefore, the regions supported by this meta-analysis deserve close attention in future studies.

29 June 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CLChi-Yu Lai
Chi-Yu Lai
SYSung-Liang Yu
Sung-Liang Yu
MHMing H. Hsieh
Ming H. Hsieh
CCChun-Houh Chen
Chun-Houh Chen
HCHsuan-Yu Chen
Hsuan-Yu Chen
WCWei J. Chen
Wei J. Chen
Since brain tissue is not readily accessible, a new focus in search of biomarkers for schizophrenia is blood-based expression profiling of non-protein coding genes such as microRNAs (miRNAs), which regulate gene expression by inhibiting the translation of messenger RNAs. This study aimed to identify potential miRNA signature for schizophrenia by comparing genome-wide miRNA expression profiles in patients with schizophrenia vs. healthy controls. A genome-wide miRNA expression profiling was performed using a Taqman array of 365 human miRNAs in the mononuclear leukocytes of a learning set of 30 cases and 30 controls. The discriminating performance of potential biomarkers was validated in an independent testing set of 60 cases and 30 controls. The expression levels of the miRNA signature were then evaluated for their correlation with the patients' clinical symptoms, neurocognitive performances, and neurophysiological functions. A seven-miRNA signature (hsa-miR-34a, miR-449a, miR-564, miR-432, miR-548d, miR-572 and miR-652) was derived from a supervised classification with internal cross-validation, with an area under the curve (AUC) of receiver operating characteristics of 93%. The putative signature was then validated in the testing set, with an AUC of 85%. Among these miRNAs, miR-34a was differentially expressed between cases and controls in both the learning (P = 0.005) and the testing set (P = 0.002). These miRNAs were differentially correlated with patients' negative symptoms, neurocognitive performance scores, and event-related potentials. The results indicated that the mononuclear leukocyte-based miRNA profiling is a feasible way to identify biomarkers for schizophrenia, and the seven-miRNA signature warrants further investigation.

1 September 1998 in American Journal of Psychiatry
Verified
Journal Article
Closed access
WCWei J. Chen
Wei J. Chen
SLShi K. Liu
Shi K. Liu
CCChing-Jui Chang
Ching-Jui Chang
YLYing-Ju Lien
Ying-Ju Lien
YCYu-Hui Chang
Yu-Hui Chang
HHHai-Gwo Hwu
Hai-Gwo Hwu